Showing results (1071-1080 of 1,139) with videos related to
Sort By:
Pageof 114
Journal of Vascular Surgery. Venous and Lymphatic Disorders|August 31, 2023
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular MedicinePeter Gloviczki, Peter F Lawrence, Suman M Wasan, et al.Phlebology|November 7, 2023
Core content for venous and Lymphatic Medicine: 2022 revisionN M Khilnani, S M Wasan, P J Pappas, et al.Regional Anesthesia and Pain Medicine|January 22, 2026
Multisociety multispecialty consensus recommendations on corticosteroid injections for facet joint and sacroiliac joint painHonorio T Benzon, Tina L Doshi, Tim Maus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyEva Segelov, Subotheni Thavaneswaran, Paul M Waring, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2018
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD databaseMohamed E Salem, Jun Yin, Benjamin A Weinberg, et al.European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.JAMA Network Open|February 16, 2021
Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary CareJoel M Stevans, Anthony Delitto, Samannaaz S Khoja, et al.The Journal of Pain|May 9, 2017
Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended ConsiderationsShannon M Smith, Judith K Jones, Nathaniel P Katz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.The Lancet. Oncology|June 5, 2023
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J Harding, Jia Fan, Do-Youn Oh, et al.Pageof 114